Peers of Inhibitor Therapeutics Inc (INTI)
Health Care · Biotechnology
Market capitalization divided by trailing twelve-month free cash flow.
Latest P/FCF Ratio
-5.29x
As of Oct 2, 2026
Beyond P/FCF Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/FCF Ratio |
|---|---|
| Oct 2, 2026 | -5.29x |
| Sep 28, 2026 | -5.39x |
| Sep 23, 2026 | -5.39x |
| Sep 22, 2026 | -3.18x |
| Sep 16, 2026 | -4.79x |
| Sep 15, 2026 | -5.39x |
| Sep 11, 2026 | -5.39x |
| Sep 9, 2026 | -4.67x |
P/FCF Ratio = Market Capitalization / Free Cash Flow (TTM)
P/FCF focuses on actual cash generation rather than accounting profit.
Read the general P/FCF Ratio definition, formula, and analyst usage guide.
P/FCF Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
